PRGO logo

Perrigo Company plc (PRGO)

$14.55

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PRGO

Market cap

$2.00B

EPS

-0.38

P/E ratio

--

Price to sales

0.48

Dividend yield

7.973%

Beta

0.394329

Price on PRGO

Previous close

$14.97

Today's open

$14.88

Day's range

$14.55 - $15.03

52 week range

$12.17 - $30.93

Profile about PRGO

CEO

Patrick Lockwood-Taylor

Employees

8379

Headquarters

Dublin 2,

Exchange

New York Stock Exchange

Shares outstanding

137624009

Issue type

Common Stock

PRGO industries and sectors

Consumer Staples

Consumer Products - Healthcare

News on PRGO

Wall Street Analysts See a 28.32% Upside in Perrigo (PRGO): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 28.3% in Perrigo (PRGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

news source

Zacks Investment Research • 8 hours ago

news preview

High Yield Revival: 3 Cash-Rich Dividend Payers on Sale

Investors aren't putting cash under their mattresses, but they're certainly looking to take some risk off the table. This means rotation out of high-growth technology stocks and looking for value.

news source

MarketBeat • Feb 20, 2026

news preview

Perrigo Announces Quarterly Dividend

DUBLIN, Feb. 19, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on March 24, 2026, to shareholders of record on March 2, 2026.

news source

PRNewsWire • Feb 19, 2026

news preview

Earnings Preview: Perrigo (PRGO) Q4 Earnings Expected to Decline

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • Feb 19, 2026

news preview

Should Value Investors Buy Perrigo (PRGO) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

news source

Zacks Investment Research • Feb 19, 2026

news preview

Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

DUBLIN, Feb. 13, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that it plans to issue its fourth quarter and fiscal year 2025 financial results on Thursday, February 26th, 2026, and host a conference call beginning at 8:30 A.M. (EST). The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 52719.

news source

PRNewsWire • Feb 13, 2026

news preview

Buy 5 IDEAL S&P 600 Small/MidCap 'Safer' February DiviDogs

The S&P 600 SmallCap index offers select high-yield 'dividend dogs' with analyst-projected net gains of 31% to 61% by February 2026. Adamas Trust stands out as the only stock ranking in the top ten for yield, target price, and total return, with positive free cash flow supporting its dividend. Only five of 56 high-yield S&P 600 stocks meet the 'IDEAL' criteria: annual dividends from $1K invested exceed share price and are covered by free cash flow.

news source

Seeking Alpha • Feb 13, 2026

news preview

3 Healthcare Stocks Paying the Highest Dividends of 2026

Despite an 8.2% forward yield, be careful with Perrigo, due to its value trap reputation. Yielding 6.7%, Pfizer is a strong choice among high-yield dividend stocks, given the company's post-COVID-19 catalysts.

news source

The Motley Fool • Feb 6, 2026

news preview

PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Jan. 19, 2026 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Perrigo Company plc ("Perrigo" or "the Company") (NYSE: PRGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 27, 2025 and November 4, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before January 16, 2026.

news source

PRNewsWire • Jan 20, 2026

news preview

Perrigo Company plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRGO

LOS ANGELES, Jan. 19, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Perrigo Company plc ("Perrigo" or "the Company") (NYSE: PRGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of PRGO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

news source

PRNewsWire • Jan 19, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Perrigo Company plc

Open an M1 investment account to buy and sell Perrigo Company plc commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PRGO on M1